R&D
Research and Development Division
R&D Division consists of:

  • DEVELOPMENT DIVISION
  • REGULATORY AFFAIRS DIVISION
  • MEDICAL AFFAIRS DIVISION
  • DEVELOPMENT DIVISION
    More than 270 products from various categories – Rx products (prescription medicines), OTC products, dietary supplements, cosmetic products, in almost all pharmaceutical forms, were developed over the course of previous 30 years.
    REGULATORY AFFAIRS DIVISION
    Hemofarm A.D. is presently the holder of 1610 Marketing Authorizations in 22 countries, as well as 92 Marketing Authorizations for medical devices and 170 Marketing Authorizations for dietary supplements. Forty-two new Marketing Authorizations were obtained and additional 100 applications for new Marketing Authorizations were submitted during 2018.
    MEDICAL AFFAIRS DIVISION
    The activities of the Medical Affairs Division are focused on:
  • Preparation of medical documentation for new products and continuous updating of documentation for the existing products
  • Continuous monitoring of each piece of new information on safety of administration and processing of all adverse reactions in post-marketing phase of our products life cycle